Back to Search
CASEY LEAMON, MD
MD
Family Medicine Physician
NPI: 1811487333IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
BP10063984(TX)S4332(TX)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
TEXAS A & M UNIVERSITY SYSTEM, HSC, COLLEGE OF MEDICINE
Class of 2018
Research & Publications (20)
The changing landscape of cancer drug discovery: a challenge to the medicinal chemist of tomorrow.
PMID 19638319·Drug Discov Today·2009
6-review
Properties influencing the relative binding affinity of pteroate derivatives and drug conjugates thereof to the folate receptor.
PMID 19189203·Pharm Res·2009
8-other
Folate targeting enables durable and specific antitumor responses from a therapeutically null tubulysin B analogue.
PMID 19047164·Cancer Res·2008
7-preclinical
Folate-targeted drug strategies for the treatment of cancer.
PMID 19037834·Curr Opin Investig Drugs·2008
6-review
Exploitation of the folate receptor in the management of cancer and inflammatory disease.
PMID 18804696·Vitam Horm·2008
6-review
Impact of high and low folate diets on tissue folate receptor levels and antitumor responses toward folate-drug conjugates.
PMID 18791065·J Pharmacol Exp Ther·2008
7-preclinical
Design and regioselective synthesis of a new generation of targeted chemotherapeutics. Part II: Folic acid conjugates of tubulysins and their hydrazides.
PMID 18657420·Bioorg Med Chem Lett·2008
7-preclinical
Low-dose radiation potentiates the therapeutic efficacy of folate receptor-targeted hapten therapy.
PMID 18411004·Int J Radiat Oncol Biol Phys·2008
7-preclinical
Folate receptor-specific antitumor activity of EC131, a folate-maytansinoid conjugate.
PMID 17616697·Cancer Res·2007
7-preclinical
An assembly concept for the consecutive introduction of unsymmetrical disulfide bonds: synthesis of a releasable multidrug conjugate of folic acid.
PMID 17602528·J Org Chem·2007
8-other
Comparative preclinical activity of the folate-targeted Vinca alkaloid conjugates EC140 and EC145.
PMID 17551919·Int J Cancer·2007
4-observational
Preclinical evaluation of EC145, a folate-vinca alkaloid conjugate.
PMID 17483358·Cancer Res·2007
7-preclinical
Preclinical pharmacokinetics, tissue distribution, and antitumor activity of a folate-hapten conjugate-targeted immunotherapy in hapten-immunized mice.
PMID 17172429·Mol Cancer Ther·2006
7-preclinical
Design and regioselective synthesis of a new generation of targeted chemotherapeutics. Part 1: EC145, a folic acid conjugate of desacetylvinblastine monohydrazide.
PMID 16870437·Bioorg Med Chem Lett·2006
8-other
Folate receptor specific anti-tumor activity of folate-mitomycin conjugates.
PMID 16331500·Cancer Chemother Pharmacol·2006
7-preclinical
Targeting therapeutic and imaging agents to folate receptor positive tumors.
PMID 15853692·Curr Pharm Biotechnol·2005
6-review
Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay.
PMID 15745749·Anal Biochem·2005
7-preclinical
Ligand binding and kinetics of folate receptor recycling in vivo: impact on receptor-mediated drug delivery.
PMID 15371560·Mol Pharmacol·2004
7-preclinical
Preclinical evaluation of (99m)Tc-EC20 for imaging folate receptor-positive tumors.
PMID 15136637·J Nucl Med·2004
7-preclinical
Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential.
PMID 15094213·Adv Drug Deliv Rev·2004
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1600 PROVIDENCE DR
WACO, TX 76707 - Phone
- (254) 313-4200
Quick Facts
- NPI
- 1811487333
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 8
- Publications
- 20
Are you this provider?
Claim Your Profile